🇺🇸 FDA
Patent

US 10111862

Traps in the treatment of macular degeneration

granted A61KA61K31/421A61P

Quick answer

US patent 10111862 (Traps in the treatment of macular degeneration) held by Aldeyra Therapeutics, Inc. expires Mon Oct 25 2038 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Aldeyra Therapeutics, Inc.
Grant date
Tue Oct 30 2018 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Oct 25 2038 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
24
CPC classes
A61K, A61K31/421, A61P, A61P27/00, A61P27/02